{"id":30489,"date":"2026-06-04T04:40:00","date_gmt":"2026-06-03T20:40:00","guid":{"rendered":"https:\/\/csccm.org.cn\/?p=30489"},"modified":"2026-06-04T10:35:30","modified_gmt":"2026-06-04T02:35:30","slug":"jama-netw-open%e5%8f%91%e8%a1%a8%e8%ae%ba%e6%96%87%ef%bc%9a%e5%a4%96%e5%91%a8%e9%9d%99%e8%84%89%e8%be%93%e6%b3%a8%e5%8d%87%e5%8e%8b%e8%8d%af%e7%89%a9%e7%9a%84%e4%b8%8d%e8%89%af%e4%ba%8b%e4%bb%b6","status":"publish","type":"post","link":"https:\/\/csccm.org.cn\/?p=30489","title":{"rendered":"[JAMA Netw Open\u53d1\u8868\u8bba\u6587]\uff1a\u5916\u5468\u9759\u8109\u8f93\u6ce8\u5347\u538b\u836f\u7269\u7684\u4e0d\u826f\u4e8b\u4ef6\u53d1\u751f\u7387"},"content":{"rendered":"\n<p>Original Investigation&nbsp;<\/p>\n\n\n\n<p>Critical Care Medicine<\/p>\n\n\n\n<h1 class=\"wp-block-heading\">Incidence of Adverse Events in Peripheral Intravenous Vasopressor Use: A Systematic Review and Meta-Analysis<\/h1>\n\n\n\n<h3 class=\"wp-block-heading\">Shang-Jun&nbsp;ZhangJian,&nbsp;Kuang-Yu&nbsp;Niu,&nbsp;Chen-Bin&nbsp;Chen,&nbsp;et al<\/h3>\n\n\n\n<h3 class=\"wp-block-heading\">JAMA Netw Open 2026;9;(3):e260710.&nbsp;doi:10.1001\/jamanetworkopen.2026.0710<\/h3>\n\n\n\n<p>Key Points<\/p>\n\n\n\n<p><strong>Question<\/strong>&nbsp;&nbsp;What is the incidence of adverse events (AEs) and avoidance of central venous catheter (CVC) placement after peripheral intravenous (PIV) administration of vasopressors in adults?<\/p>\n\n\n\n<p><strong>Findings<\/strong>&nbsp;&nbsp;In this systematic review and meta-analysis of 49 studies including 33\u202f060 catheters, pooled incidence of minor AEs for all PIV vasopressors was 2%, while pooled incidence of major AEs was 1% for midline and 0% for short PIV catheters. Pooled incidence of CVC avoidance was 60%.<\/p>\n\n\n\n<p><strong>Meaning<\/strong>&nbsp;&nbsp;In this study, the incidence of AEs after short-term vasopressor administration through PIV catheters was low, and the findings suggest that with appropriate monitoring, PIV administration might reduce the need for CVC placement.<a><\/a><\/p>\n\n\n\n<p>Abstract<\/p>\n\n\n\n<p><strong>Importance<\/strong>&nbsp;&nbsp;Peripheral intravenous (PIV) vasopressors are increasingly used but remain associated with adverse events (AEs). Quantifying the incidence of these AEs is essential to guide clinical decision-making regarding PIV vasopressor use.<\/p>\n\n\n\n<p><strong>Objective<\/strong>&nbsp;&nbsp;To assess the incidence of AEs and avoidance of central venous catheter (CVC) placement after PIV vasopressor administration in adults with hypotension, shock, or critical illness.<\/p>\n\n\n\n<p><strong>Data Sources<\/strong>&nbsp;&nbsp;PubMed, Embase, and the Cochrane Central Register of Controlled Trials were searched from inception to December 13, 2025, using medical subject headings and keywords related to peripheral vasopressors.<\/p>\n\n\n\n<p><strong>Study Selection<\/strong>&nbsp;&nbsp;Eligible studies included critically ill adults receiving vasopressors via PIV catheters and reported AEs and\/or CVC avoidance.<\/p>\n\n\n\n<p><strong>Data Extraction and Synthesis<\/strong>&nbsp;&nbsp;Following Preferred Reporting Items for Systematic Reviews and Meta-Analyses guidelines, 2 investigators independently extracted data and assessed risk of bias. A random-effects model was used, and proportions were pooled using a generalized linear mixed model.<\/p>\n\n\n\n<p><strong>Main Outcomes and Measures<\/strong>&nbsp;&nbsp;The primary end point was the pooled incidence of AEs as the proportion among total catheters, and the secondary end point was the pooled proportion of CVC avoidance.<\/p>\n\n\n\n<p><strong>Results<\/strong>\u00a0\u00a0Forty-nine studies including 33\u202f060 catheters were analyzed. The pooled minor AE incidence was 2.6% (95% CI, 1.4%-4.7%) for norepinephrine, 0.0% (95% CI, 0.0%-24.6%) for epinephrine, 2.9% (95% CI, 1.8%-4.8%) for phenylephrine, 1.4% (95% CI, 0.3%-5.9%) for dopamine, 0.5% (95% CI, 0.1%-1.8%) for vasopressin, and 0.9% (95% CI, 0.1%-11.5%) for metaraminol. When considering all vasopressors collectively, the pooled minor AE incidence was 2.3% (95% CI, 1.5%-3.7%). Regarding major AEs, 30 venous thromboembolism events occurred, all in the 4 studies (8.1%) using midline catheters (1126 total catheters), with a pooled incidence of 1.4% (95% CI, 0.4%-5.4%). In contrast, only 1 major AE (a tissue necrosis event) was reported in 43 studies (87.8%) using short PIV catheters (29\u202f596 total catheters), with a pooled incidence of 0.0% (95% CI, 0.0%-0.0%). CVC avoidance ranged from 0% to 100%, with a pooled proportion of 59.7% (95% CI, 46.4%-71.7%) in 38 studies (77.6%) including 15\u202f371 catheters.<\/p>\n\n\n\n<figure class=\"wp-block-image size-large\"><img decoding=\"async\" src=\"https:\/\/cdn.jamanetwork.com\/ama\/content_public\/journal\/jamanetworkopen\/939795\/zoi260047f1_1773073667.29526.png?Expires=1782468656&amp;Signature=I9CSRaYgFofcCIp17~T9VWFyK7moC0KfqhSSs-HksedlTtepLLsY2u66GCM7MaflITmInkHqdZbuChUkiu~6m99NK-B84QS2wu5bArnjA2aJT8E8P4eEGGhg61kj70dveHngunJ6Xy2GZdRA0dBXJjOLJCTv~ne~qMT1l2klmy5Rhw~Dyr0cVFkiwlw7S6kpQwpstCcHoC1VO3rdmeadNYzDg81hqF8BdJjpXu0DKf1~dZqoRi9WM6-5neyryNfYPpKiPYmDQ8DEnwCBBWzZUxdODKfGrzr2V5HeEqLGs3XISHr99nvgPV2edahRNikh5pKsDibpsBBsw~-Bl0latg__&amp;Key-Pair-Id=APKAIE5G5CRDK6RD3PGA\" alt=\"\"\/><\/figure>\n\n\n\n<figure class=\"wp-block-image size-large\"><img decoding=\"async\" src=\"https:\/\/cdn.jamanetwork.com\/ama\/content_public\/journal\/jamanetworkopen\/939795\/zoi260047f2_1773073667.32526.png?Expires=1782468656&amp;Signature=1Ujq89zBMs7HriXtO4uucTkW1oszjiJ7wg0kpTcA5QfOjBtqaclYdcvHv3NLB7rTbeZ1Bz9Hc49BEP-00QtGLQJCtPISlG4om08uZYM5Z1CAQxG1T1YWGBTMBHt0o3Y~0aQKqibJNlzoK2HTT5lkazSTmeglmspCISlCx2Y5lMEaX9w9lSbVCJov8dw~G~pEIrz8qm7fO5AjFH0JkInd9MEj0J7RqhwxZ3BHXFRF9Giz-bbqQOF2l1TvKFW1-flVOgAsyW12vLQYRzpzuMHtooeFuxS89cQlPPa~kptOjKhAEj0ytCtgj6T9kSHPbkp8rkmVufWan14A7k-ELYucNg__&amp;Key-Pair-Id=APKAIE5G5CRDK6RD3PGA\" alt=\"\"\/><\/figure>\n\n\n\n<figure class=\"wp-block-image size-large\"><img decoding=\"async\" src=\"https:\/\/cdn.jamanetwork.com\/ama\/content_public\/journal\/jamanetworkopen\/939795\/zoi260047f3_1773073667.33526.png?Expires=1782468656&amp;Signature=spAWXH4~A7VvC74FGOYZestvaLHxF1Vw88VsOAdIpoWsoZxZnWDp~Ea7iEQkfdOJ3HzH9hm62mkJbJkpLJ8ZQaMkSaEkYmolJ7fOprICZyWH787cMC4Wq6UiXLPb5FhSJa00HrXjUbrgbPJ7habV0HVNHYYeTPCg0ufndrvaL-SbnrrwJkrkc3c0oyxtJxRak5FtbiMD79PBfylxXQc9NqeU3R2tF2bu-hkLB8nA~L6AIfUbOjwTykKX0wNygwYg~Wt2TFPjzvFUSLKSKuIxnJR-AGI9gsh7B0tR62m4ZqlU9SR8hn1ebHg3sN6Sf1en0K9fYuT~-MVLIARNsY1-~g__&amp;Key-Pair-Id=APKAIE5G5CRDK6RD3PGA\" alt=\"\"\/><\/figure>\n\n\n\n<figure class=\"wp-block-image size-large\"><img decoding=\"async\" src=\"https:\/\/cdn.jamanetwork.com\/ama\/content_public\/journal\/jamanetworkopen\/939795\/zoi260047f4_1773073667.34026.png?Expires=1782468656&amp;Signature=AU-vP09gklKerck7i81VuoxIUYwSpGsqAkMJU-C1cnaf4-7KveVVtrfBxBRKEZKvTIuQNC1bpiMgsqiu76dSz8TJVtHvyO97uNbMHpv-53kQA9iXycDE9wltbZWORMaI9EG5822L330iwTlNEtHnXipJdANzMrUrZCoYsquL7JqGrmIz53~ievdZDZflVITqedpSzoIY6CbkhjKRERO4tuNQvFsUYOa19bp5Pbzb4fS5BGP-AjRcvRaCM5zTB90NZw1hSmgCikweHaE1kDZbyYel-IqhhWoct3cyT6rXO~xG4pYC4ilLTUwHCvnbkmTsLrKixnKkWu87UoEWMfkPSg__&amp;Key-Pair-Id=APKAIE5G5CRDK6RD3PGA\" alt=\"\"\/><\/figure>\n\n\n\n<figure class=\"wp-block-image size-large\"><img decoding=\"async\" src=\"https:\/\/cdn.jamanetwork.com\/ama\/content_public\/journal\/jamanetworkopen\/939795\/zoi260047t1_1773073667.31026.png?Expires=1782468997&amp;Signature=foimACs5wpVP34kw5tmkEUnzMEHgsVFse-vdZ7m6CdbSi9PAncCIEuKl9icTdwoDY5lklIZcuPyhZ~jtpJ-PH5Hs9j~l-JT27oI-DAOxdGXKB3Y61huuxw2qFBhmderVirQT7dQ-pa~-cF~gfWrZi2gxMWSH930AGidIRqB2yQCH6t25eRE~C4l5SSI7CeMLXrR0w38opsI~JAz92pvrZVNe54YNw0PadT9Ztythm88HAbtISX381p6CqippMZDtbpQilhG6C2WtdED4B5by3EzIk-vMKm490idVm8t2BZu0~TTVyZcHpcbSPHDUEx6VA9fhWy3kD5xhUAP92sR0nQ__&amp;Key-Pair-Id=APKAIE5G5CRDK6RD3PGA\" alt=\"\"\/><\/figure>\n\n\n\n<p><strong>Conclusions and Relevance<\/strong>&nbsp;&nbsp;In this systematic review and meta-analysis of adult patients, AE incidence was low after short-term vasopressor administration through PIV catheters, particularly short catheters. These findings suggest that PIV administration might reduce the need for CVC placement with appropriate monitoring.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Original Investigation&nbsp; Critical Care Medicine Inc [&hellip;]<\/p>\n","protected":false},"author":3,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":[],"categories":[32,23],"tags":[],"_links":{"self":[{"href":"https:\/\/csccm.org.cn\/index.php?rest_route=\/wp\/v2\/posts\/30489"}],"collection":[{"href":"https:\/\/csccm.org.cn\/index.php?rest_route=\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/csccm.org.cn\/index.php?rest_route=\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/csccm.org.cn\/index.php?rest_route=\/wp\/v2\/users\/3"}],"replies":[{"embeddable":true,"href":"https:\/\/csccm.org.cn\/index.php?rest_route=%2Fwp%2Fv2%2Fcomments&post=30489"}],"version-history":[{"count":2,"href":"https:\/\/csccm.org.cn\/index.php?rest_route=\/wp\/v2\/posts\/30489\/revisions"}],"predecessor-version":[{"id":31041,"href":"https:\/\/csccm.org.cn\/index.php?rest_route=\/wp\/v2\/posts\/30489\/revisions\/31041"}],"wp:attachment":[{"href":"https:\/\/csccm.org.cn\/index.php?rest_route=%2Fwp%2Fv2%2Fmedia&parent=30489"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/csccm.org.cn\/index.php?rest_route=%2Fwp%2Fv2%2Fcategories&post=30489"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/csccm.org.cn\/index.php?rest_route=%2Fwp%2Fv2%2Ftags&post=30489"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}